BNET Industries

ZIOPHARM Oncology Inc.

(ZIOP) is in the Pharma Industry

Market Cap:$95.3M
  • Public
  • US
Dow Jones Description

Our business plan has been prepared based upon the popularity of the Internet and the growing number of businesses interested in advertising and marketing online. From our inception through December 31, 2004, we have sold less than ten web sites and realized only minimal revenue of $9,547 from the design, sale and maintenance of Internet sites. Our operations were very limited during the year ended December 31, 2004. We did not perform any services or earn any revenue during 2004. We are currently dependent upon an affiliate, Summit Financial Relations, Inc. ("Summit"), which has paid expenses on our behalf, in order to maintain our limited operations. We have also received working capital advances from our president, Mr. David C. Olson. There is no assurance that Summit or Mr. Olson will continue to pay our expenses and provide working capital in the future. Our future success will be dependent upon our ability to locate and consummate a merger or acquisition with an operating company and, ultimately, to attain profitability. There is no assurance that we will be successful in consummating a merger or acquisition with an operating company or that we will attain profitability.

Chief Executive Officer
Jonathan Lewis
Number of Employees 17
Contact Information

1180 Ave of the Americas 19th Fl

New York, New York 10036-8401

www.ziopharm.co...

(617) 214-0700

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • ZIOPHARM, Inc. Reports Third Quarter Financial Results and Updated Clinical Progress

    11/11/09 - Financial Announcement - View Story

  • ZIOPHARM Reports Second Quarter Financial Resultsand Updates Clinical Programs

    8/14/09 - Financial Announcement - View Story

News & Analysis

ziopharm oncology inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Jonathan Lewis Chief Executive Officer
Richard E. Bagley President, CFO, COO & Treasurer
Barbara Wallner Chief Technical Officer
Barry Jones Senior Vice President, Preclinical Operations
Bob Morgan Senior Vice President, Regulatory Affairs, Quality & Clinical Dev
Robert Peter Gale Senior Vice President of Research
Janice Stevens Vice President, Clinical Operations
John Amedio Vice President, Manufacturing & Process Dev
Steven Bloom Vice President, Business Dev
Suzanne McKenna Manager, IR

Board of Directors

Name (plus bio) Position
Gary S. Fragin Board of Directors
James A. Cannon Board of Directors
Michael Weiser Board of Directors
Murray Brennan Board of Directors
Sen Wyche Fowler Board of Directors
Timothy McInerney Board of Directors
W. Wyche Fowler Board of Directors

Dr. Lewis has been a Director since June 2007. Dr. Lewis is Chief Executive Officer of ZIOPHARM Oncology, Inc. He has held leadership positions at the Memorial Sloan-Kettering Cancer Center, Yale-New Haven Hospital, Yale University School of Medicine and Cornell University Medical School. He was Chief Medical Officer of Antigenics, Inc. from 2000 to 2003. Dr. Lewis earned his MB.B.Ch. from Witwatersrand University School of Medicine (Johannesburg, South Africa) and his Ph.D. in Molecular Biology from Witwatersrand and Yale University School of Medicine. Dr. Lewis conducted his Surgical Residency at Johannesburg General Hospital, Witwatersrand University School of Medicine and at Yale-New Haven Hospital, Yale University School of Medicine. He is a Fellow of both the Royal College of Surgeons and the American College of Surgeons. Dr. Lewis was a Research Fellow in the Department of Surgery and Molecular Biophysics and Biochemistry at Yale University School of Medicine, and was a Postdoctoral Fellow in the Department of Immunology and Surgery at Memorial Sloan-Kettering Cancer Center.

Organization Position Status
Ziopharm Oncology, Inc. Chief Executive Officer Current
Ziopharm, Inc Director and Chief Executive Officer (Principal Executive Officer) Current
Ziopharm, Inc Board of Directors Current
Ziopharm Oncology, Inc. Board of Directors Current
American College of Surgeons Fellow Current
Memorial Sloan-Kettering Cancer Center Inc. Executive Member Current
Ziopharm, Inc Chief Executive Officer and Executive Chairman Former
Antigenics Inc. Chief Medical Officer Former
Memorial Sloan-Kettering Cancer Center Inc. Professor Former
Antigenics Inc. Chairman Former

Organization Position Status
Ziopharm Oncology, Inc. President, CFO, COO & Treasurer Current
Ziopharm Oncology, Inc. Board of Directors Current

Barbara Wallner, Ph.D., Senior Vice President for Technical Operations and Chief Technical Officer, ZIOPHARM Oncology, Inc. Dr. Wallner is currently Senior Vice President for Technical Operations, Chief Technical Officer at ZIOPHARM Oncology, Inc. Before that she was Chief Scientific Officer and Senior Vice President for Research at BioTransplant, Inc. Dr. Wallner is a cofounder of Point Therapeutics and the former Senior Vice President for Research and Development, and Chief Scientific Officer at Point. Prior to that she was Vice President, Research at Immulogic, Inc. and held several management positions at Biogen, Inc.

Organization Position Status
Ziopharm Oncology, Inc. Chief Technical Officer Current
Point Therapeutics Senior Vice President for Technical Operations and Chief Technical Officer, Ziopharm Oncology, Inc. Current
Ziopharm, Inc Chief Technology Officer Current
Bio Transplant Incorporated Senior Vice President Former
Ziopharm Oncology, Inc. Senior Vice President for Technical Operations Former
Biogen, Inc. Vice President, Research Former
Point Therapeutics Co-Founder Former

Organization Position Status
Ziopharm Oncology, Inc. Senior Vice President, Preclinical Operations Current

Organization Position Status
Ziopharm Oncology, Inc. Senior Vice President, Regulatory Affairs, Quality & Clinical Dev Current
Ziopharm Oncology, Inc. Vice President, Regulatory Affairs & Quality Former

Organization Position Status
Ziopharm Oncology, Inc. Senior Vice President of Research Current
Biocatalyst Associates Current
Center for Advanced Studies Chairman Current
Robert Peter Gale Board of Directors Current
American College of Physicians Fellow Current
Advanced Studies President Former
Antigenics Inc. Senior Vice President for Medical Affairs Former
Salick Health Care, Inc. Corporate Director of Bone Marrow and Stem Cell Transplantation Former
Salick Health Care, Inc. Senior Physician Former
Zeneca Board of Directors Former
University of California, Los Angeles PhD In Microbiology Former
State University of New York at Buffalo M.D. Degree Former
Hobart and William Smith Colleges A.B. Degree Former
Zeneca Member Former

Organization Position Status
Ziopharm Oncology, Inc. Vice President, Clinical Operations Current

Organization Position Status
Ziopharm Oncology, Inc. Vice President, Manufacturing & Process Dev Current

Organization Position Status
Ziopharm Oncology, Inc. Vice President, Business Dev Current
Cary Pharmaceuticals Inc Board of Directors Current
Northeastern University Bachelor of Science Degree In Pharmacy Former

Organization Position Status
Ziopharm Oncology, Inc. Manager, IR Current

Organization Position Status
Ziopharm Oncology, Inc. Board of Directors Current

Organization Position Status
Ziopharm Oncology, Inc. Board of Directors Current

Organization Position Status
Chelsea Therapeutics International, Ltd. Interim President Current
Manhattan Pharmaceuticals, Inc. Vice President Current
Vioquest Pharmaceuticals, Inc. Founder and Co-Chairman of Actin Biomed Current
Ziopharm, Inc Founder and Co-Chairman of Actin Capital, Llc and Actin Biomed Current
Chiral Quest, Inc. Director of Research of Paramount Biocapital Asset Management Current
Hana Biosciences, Inc. Board of Directors Current
Chiral Quest, Inc. Board of Directors Current
Ziopharm Oncology, Inc. Board of Directors Current
Vioquest Pharmaceuticals, Inc. Board of Directors Current
Paramount Acquisition Corp Board of Directors Current
Chelsea Therapeutics International, Ltd. Board of Directors Current
Ziopharm, Inc Board of Directors Current
Emisphere Technologies, Inc. Board of Directors Current
Paramount Biosciences, LLC Director of Research Former
Actin Inc Former
Weill Medical College of Cornell University Ph.D. in Molecular Neurobiology Former
New York University School of Medicine M.D. Former
University of Vermont B.A. In Psychology Former
Manhattan Pharmaceuticals, Inc. member Former

Organization Position Status
Ziopharm Oncology, Inc. Board of Directors Current

Organization Position Status
Ziopharm Oncology, Inc. Board of Directors Current

Organization Position Status
Riverbank Capital LLC Current
Ziopharm, Inc Committee Chair for Nominating Committee Current
Ziopharm, Inc Board of Directors Current
The Manhattan Director Current
Manhattan Pharmaceuticals, Inc. Board of Directors Current
Ziopharm Oncology, Inc. Board of Directors Current
The Bear Stearns Companies Inc. Former
Bristol-Myers Squibb Company Former
St. John and Company B.S. In Pharmacy Former
St. John's University B.S. In Pharmacy Former
New York University Medical Center post-graduate residency Former

Organization Position Status
Ziopharm Oncology, Inc. Board of Directors Current
advertisement
     ZIOP $3.77 +0.10 (2.72% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 202,959
Shares Outstanding 25.57M
Market Cap 96.4M
Year High 4.1
Year Low 0.5
Earnings Per Share -0.62
P/E Ratio -6.08
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement